Statin use and survival from lung cancer: a population-based cohort study.
about
Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible LinkFrom Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals.Impact of Statins on Gene Expression in Human Lung Tissues.Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study.Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma.Long-term statin use in patients with lung cancer and dyslipidemia reduces the risk of death.Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients.Risk of cause-specific death in individuals with cancer - modifying role diabetes, statins, and metformin.Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivityMyocardial infarction and future risk of cancer in the general population-the Tromsø Study.The effect of statins on survival in patients with stage IV lung cancer.Guideline-Based Statin Eligibility, Cancer Events, and Noncardiovascular Mortality in the Framingham Heart Study.Catan-ionic hybrid lipidic nano-carriers for enhanced bioavailability and anti-tumor efficacy of chemodrugs.A quality by design approach for the development of lyophilized liposomes with simvastatin.YAP1 is essential for tumor growth and is a potential therapeutic target for EGFR-dependent lung adenocarcinomas.An image-based small-molecule screen identifies vimentin as a pharmacologically relevant target of simvastatin in cancer cells.Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR).YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.Simvastatin Suppresses Proliferation and Migration in Non-small Cell Lung Cancer via Pyroptosis.No room for statins in the quest for survival benefits in small cell lung cancer.Estrogen Receptor Beta-Mediated Modulation of Lung Cancer Cell Proliferation by 27-Hydroxycholesterol
P2860
Q26799973-1C9105D9-85D4-4869-8010-2FD32AB06943Q28552102-2E87787D-9C34-4FEB-BD03-FC413C4D4227Q30241078-36160F6B-3E55-42FE-8656-E82303507CD5Q35831665-7E035C4E-0B15-4FD2-9B6D-6B114E370CFFQ36269651-7035ED8B-A76B-4FE4-8452-6FBD97896A0AQ36729421-FC0DC312-6D37-498B-8079-5BA83CC8F5CAQ37520501-BD78EFC4-2C32-4805-ACCD-FAA2D78D165EQ37628134-55509913-44FB-445A-B2F2-5D226066AD65Q38398847-93149C25-F617-453B-AACB-32878D3CF4E2Q38633269-C411DCE4-2238-42C3-9057-89BB39B135FDQ38760099-59B99E92-BE0D-427B-B653-DA47299E14B7Q39449460-8FC157A2-94D6-474E-B0A8-82DE19ED0F3CQ40125992-7108581B-11ED-4172-9848-224D4361EEA4Q42223300-A0651CC7-9FA2-4D38-BE01-3361A68B7C3BQ47130348-B5BE460B-9A3D-4C41-AEA3-84D165763EE3Q47139623-840A45F9-90B9-4A33-AB81-0CF81DE221A3Q52733697-7EAC4789-3743-4768-B60E-4D35C43A60F3Q53476716-769E64C9-1519-403C-84F7-43E073152579Q53686708-8DEC9F38-0B17-4AE2-9514-A128C60A4C2AQ54960976-F8897B40-CB8C-4976-B41D-8356C6CB6D74Q55062496-49A06319-448F-480F-B0F6-F4AA5131A7EFQ58712246-91CDFEC9-3398-45F9-B822-6585058B1117
P2860
Statin use and survival from lung cancer: a population-based cohort study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Statin use and survival from lung cancer: a population-based cohort study.
@en
type
label
Statin use and survival from lung cancer: a population-based cohort study.
@en
prefLabel
Statin use and survival from lung cancer: a population-based cohort study.
@en
P1476
Statin use and survival from lung cancer: a population-based cohort study
@en
P2093
Carmel M Hughes
Liam J Murray
P304
P356
10.1158/1055-9965.EPI-15-0052
P577
2015-05-01T00:00:00Z